| abstract |
The present invention provides methods, systems, and compositions comprising novel peptidomimetics that can be used to treat tissue damage resulting from inhibition of calpain, particularly pathological activation of calpain. Disclosed are methods, systems, and compositions that include novel peptidomimetics that can be used to inhibit calpain, particularly to treat tissue damage resulting from pathological activation of calpain. [Selection] Figure 1 |